Text from full page Diabetes Forecast Ad
MARCH, 1995 - This is a computer program with a mission," says Dr. S. E. Stanton, president of ITA Software, Inc. "We're trying to reach out to people with diabetes whose highs are too high and whose lows are too low." That's where ITA's diabetology computer program can help.
Dr. Stanton's company markets "Insulin Therapy Analysis" for WindowsTM, a computer program that simulates diabetes and its affect on the blood glucose in the body. Written by Dr. Stanton, an 18-year college professor and researcher, the computer program accomplishes the awesome task of placing the full medical algorithm for diabetes onto your PC.
"The miracle of the point-and-click graphical interface has made this program possible," said Stanton. "Now anyone, any time, can bring the science of diabetes protocol analysis to bear on their regime. It is no longer just a clinical tool.
"ITA is not a toy," says Dr. Stanton. It is high quality diabetology software written by credentialed professionals. And it is user-friendly in the truest sense of the cliche: everything is point and click.
After entering personal data, the user points and clicks the mouse; an extremely complex algorithmic process is executed simulating 24 hours of diabetes; and the user sees the results, displayed graphically.
"The user sees, perhaps for the first time, what any regime is expected to do," Stanton said. "The results exemplified can be very candid. The chart is simple enough for everyone to understand, and very informative."
Dr. Stanton says that 9 out of 10 regimes he sees have serious inherent flaws that the user doesn't know are there. "Even carefully crafted regimes have flaws. Without running the numbers," he said, "it is nearly impossible to be problem free. The more we see the results, the better we like this program".
Dr. Stanton said that his wife, Colina Stanton, MS, RD, who is a health professional with diabetes, led him through the job of making the program exemplify results by means of charted data useful to self-managers.
"Our goal was to end the awful trial and error struggle," said Stanton. "The user inspects the results presented by the program, finds the flaws, fixes the regime, and repeats the simulation. The user soon converges on the regime that fits his/her lifestyle and still meets target glucose levels."
And the results work: "These are accepted medical algorithms backed by years of hospital clinical results. It's not surprising, then, that adhering to an ITA-derived plan improves blood sugar results."
"If you develop a regime to fit your lifestyle," says Stanton, "the discipline required for excellent results is lessened considerably."
Dr. Stanton's diebetology software might not solve everyone's problems, he said, "but it can put you on the best track that modern biotechnology can provide."